| 12/03 | Novavax Statement on Omicron Variant Response | AQ |
| 12/02 | NOVAVAX : StatementCOVID-19 | PU |
| 12/01 | NOVAVAX, INC. SHAREHOLDER ALERT : Robbins LLP Informs Reminds of Class Action Against Nova.. | BU |
| 11/24 | Novavax Files for Interim Authorization of COVID-19 Vaccine in Singapore | PR |
| 11/23 | Novavax to Participate in Evercore ISI's 4th Annual HealthCONx Virtual Conference | PR |
| 11/18 | EMA receives application for conditional marketing authorisation of Novavax's COVID-19 .. | AQ |
| 11/18 | NOVAVAX : StatementCOVID-19 | PU |
| 11/17 | Novavax asks EU drug regulator to OK its COVID vaccine | AQ |
| 11/17 | HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Novavax (NVAX) Investors with Signi.. | PR |
| 11/17 | Novavax Confirms European Medicines Agency Review of COVID-19 Vaccine Filing for Condit.. | AQ |
| 11/17 | Alcami to provide analytical support services for novavax' covid-19 vaccine candidate | AQ |
| 11/17 | Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 V.. | AQ |
| 11/16 | SHAREHOLDER ALERT : Robbins LLP Informs Investors of Class Action Against Novavax, Inc. (N.. | BU |
| 11/15 | Novavax Announces Submission of Biologics License Application in South Korea for Approv.. | PR |
| 11/11 | Novavax Statement on UK and Mexico Phase 3 Clinical Trial Participants Considered Fully.. | AQ |
| 11/10 | StatementCOVID-19 | PU |
| 11/05 | Novavax Reports Third Quarter 2021 Financial Results and Operational Highlights - Form .. | PU |
| 11/05 | NOVAVAX INC Management's Discussion and Analysis of Financial Condition and Results
of.. | AQ |
| 11/04 | NOVAVAX : Q3 Earnings Snapshot | AQ |
| 11/04 | Novavax Reports Third Quarter 2021 Financial Results and Operational Highlights | PR |
| 11/04 | Novavax Files COVID-19 Vaccine for Emergency Use Listing with World Health Organization | PR |
| 11/04 | SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novav.. | PR |
| 11/03 | Novavax Files COVID-19 Vaccine for Provisional Approval in New Zealand | PR |
| 11/02 | NVAX INVESTOR NEWS : ROSEN, A TOP RANKED LAW FIRM, Encourages Novavax, Inc. Investors with.. | PR |
| 11/02 | Indonesia first to approve Novavax COVID-19 vaccine for emergency use | AQ |
| 11/01 | NOVAVAX INC : Entry into a Material Definitive Agreement (form 8-K) | AQ |
| 11/01 | Novavax, Harley-Davidson rise; Moderna, Mirati fall | AQ |
| 11/01 | Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia | AQ |
| 11/01 | Biotech firm Novavax submits COVID-19 vaccine for approval by Health Canada | AQ |
| 11/01 | Corporate and FinanceCOVID-19 | PU |
| 11/01 | Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 V.. | PR |
| 11/01 | Novavax Files for COVID-19 Vaccine Authorization with Health Canada and Completes Submi.. | PR |
| 10/29 | Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia | PR |
| 10/27 | Novavax Files for Authorization of its COVID-19 Vaccine in the United Kingdom - Form 8-.. | PU |
| 10/27 | NOVAVAX INC : Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
| 10/27 | Novavax Files for Authorization of its COVID-19 Vaccine in the United Kingdom | PR |
| 10/25 | THE LAW OFFICES OF FRANK R. CRUZ : Announces Investigation of Novavax, Inc. (NVAX) on Beha.. | BU |
| 10/25 | INVESTIGATION NOTICE : The Schall Law Firm Announces it is Investigating Claims Against No.. | PR |
| 10/25 | NOVAVAX ALERT : Bragar Eagel & Squire, P.C. Is Investigating Novavax, Inc. on Behalf of No.. | BU |
| 10/22 | INVESTIGATION REMINDER : The Schall Law Firm Announces it is Investigating Claims Against .. | BU |
| 10/22 | INVESTOR ALERT : Law Offices of Howard G. Smith Announces Investigation of Novavax, Inc. (.. | BU |
| 10/21 | INVESTIGATION ALERT : The Schall Law Firm Announces it is Investigating Claims Against Nov.. | BU |
| 10/21 | GLANCY PRONGAY & MURRAY LLP : a Leading Securities Fraud Law Firm, Announces Investigation.. | BU |
| 10/21 | NOVAVAX : HAGENS BERMAN, NATIONAL TRIAL ATTOREYS, Encourages Novavax (NVAX) Investors with.. | PR |
| 10/21 | NOVAVAX : Reconfirms Confidence in Regulatory Filing Timelines and Manufacturing Quality | AQ |
| 10/20 | EQUITY ALERT : Rosen Law Firm Encourages Novavax, Inc. Investors with Losses to Inquire Ab.. | BU |
| 10/20 | Novavax Statement on Initial Com-COV2 Phase 2 Clinical Trial Results Presented at World.. | AQ |
| 10/19 | NOVAVAX : StatementCOVID-19 | PU |
| 10/18 | NOVAVAX : to Host Conference Call to Discuss Third Quarter Financial Results and Operation.. | PR |
| 10/15 | NOVAVAX : to Participate in World Vaccine Congress Europe | PR |
| 10/12 | NOVAVAX : Complete PREVENT-19 Phase 3 Clinical Trial Results Manuscript for COVID-19 Vacci.. | AQ |
| 10/11 | NOVAVAX : StatementCOVID-19 | PU |
| 10/08 | NOVAVAX : UK to offer new vaccine shots to Novavax trial volunteers | AQ |
| 10/04 | NOVAVAX : Announces Leadership Appointment and Updates | PR |
| 09/29 | NOVAVAX : to Participate in Health Equity and Vaccine Confidence Panel at Maryland Life Sc.. | PR |
| 09/27 | NOVAVAX : Hosts HM King Carl XVI Gustaf and HM Queen Silvia of Sweden During Royal Visit t.. | AQ |
| 09/24 | NOVAVAX : Hosts HM King Carl XVI Gustaf and HM Queen Silvia of Sweden During Royal Visit t.. | PR |
| 09/23 | NOVAVAX : Results from Novavax NanoFlu Influenza Vaccine Phase 3 Clinical Trial Published .. | AQ |
| 09/23 | NOVAVAX : Results from Novavax NanoFlu Influenza Vaccine Phase 3 Clinical Trial Published .. | PR |
| 09/23 | THE LATEST : Novavax asks vaccine be granted emergency use | AQ |
| 09/23 | NOVAVAX : and Serum Institute of India Announce Submission to World Health Organization fo.. | PR |
| 09/23 | NOVAVAX : and Serum Institute of India Announce Submission to World Health Organization fo.. | AQ |
| 09/23 | NOVAVAX : to Participate in Fireside Chat at the 2021 Cantor Virtual Global Healthcare Con.. | PR |
| 09/20 | NOVAVAX : to Participate in Fireside Chat at Devex @ UNGA 76 | PR |
| 09/20 | NOVAVAX : Statement on Proof of COVID-19 Vaccine Requirements for PREVENT-19 Clinical Tria.. | AQ |
| 09/20 | NOVAVAX : 15,000 Brits who took part in Novavax trials unable to prove Covid vaccine statu.. | AQ |
| 09/17 | NOVAVAX : StatementCOVID-19 | PU |
| 09/16 | NOVAVAX : to Participate in University of Oxford Com-COV3 Study Comparing Mixed COVID-19 V.. | PR |
| 09/13 | TAKEDA PHARMACEUTICAL : Novavax Statement on Takeda Agreement to Provide 150 Million Doses.. | AQ |
| 09/10 | NOVAVAX : StatementCOVID-19 | PU |
| 09/09 | NOVAVAX INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) | AQ |
| 09/09 | NOVAVAX : to Participate in Upcoming September Conferences | PR |
| 09/08 | NOVAVAX : Initiates Phase 1/2 Clinical Trial of Combination Vaccine for COVID-19 and Seaso.. | PR |
| 09/07 | NOVAVAX : to Participate in Citi's 16th Annual BioPharma Virtual Conference 2021 | PR |
| 08/30 | NOVAVAX : Statement on CDC Guidance Update for COVID-19 Clinical Trial Participants | PR |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
